Technetium-99m-MAG3 renal studies in spinal cord injury patients: Normal range, reproducibility, and change as a function of duration and level of injury

Spinal Cord

Volumn 34, Issue 6, 1996, Pages 338-345

  Klingensmith III, W C ^a,b   Lammertse, D P ^a   Briggs, D E ^a   Smith, W I ^a   Roberts, J F ^a   Froelich, J W ^a   Sutherland, J D ^a  

^a Radiology Imaging Associates   (United States)

^b NONE   (United States)

Author keywords

paraplegia; renal clearance; renal studies; reproducibility; Tc 99m mercaptoacetyltriglycine (MAG3); tetraplegia

Indexed keywords

MERTIATIDE TC 99M; TECHNETIUM 99M;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; PARAPLEGIA; PRIORITY JOURNAL; SPINAL CORD INJURY;

EID: 0029898773     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sc.1996.62     Document Type: Article

References (29)

1. Vera A, Merritt JL, Erickson BR. Renal function in spinal cord injury: A preliminary report. Arch Phys Med Rehabil 1986; 67: 257-259.
2. Stover SO. Renal function tests on spinal cord injury patients. In Research Update. Spain Rehabilitation Center, Birmington, AL, USA, 1990.
3. Lloyd AL, Dubovsky CVD, Bueschen AJ et al. Comprehensive renal scintillation procedures in spinal cord injury. Comparison with excretory urography. J Urol 1981; 126: 10-13.
4. Eshima D, Taylor A. Technetium-99m (99mTc) mercaptoacetyltriglycine: Update on the new 99mTc renal tubular function agent. Sem Nucl Med 1992; 22: 61-73.
5. Klingensmith WC, Briggs DE, Smith WI. Technetium-99m-MAG3 renal studies: Normal range and reproducibility of physiologic parameters as a function of age and sex. J Nucl Med 1994; 35: 1612-1617.
6. Klingensmith WC, Tyler HN, Marsh WE, et al. Effect of hydration and dehydration on technetium-99m CO2 DADS renal studies in normal volunteers. J Nucl Med 1985; 26: 875-879.
7. Gates GF. Glomerular filtration rate: Estimation from fractional renal accumulation of Tc-99m-DTPA (stannous). Am J Roentgenol 1982; 138: 565-570.
8. Gates GF. Split renal function testing using Tc-99m DTPA: A rapid technique for determining differential glomerular filtration. Clin Nucl Med 1983; 8: 400-407.
9. Schlegel JU, Hamway SA. Individual renal plasma flow determination in 2 minutes. J Urology 1976; 116: 282-285.
10. Harbert JC, Curl FB, Jones GW. The effect of injection volume and technique on radionuclide cerebral angiograms. J Nucl Med 1973; 14: 205-207.
11. Price M, Tobin JA, Reiser M, et al. Renal function in patients with spinal cord injuries. Arch Phys Med Rehabil 1966; 47: 406-411.
12. Kuhlemeier KV, McEachran AB, Lloyd AL, et al. Renal function after acute and chronic spinal cord injury. J Urology 1984; 131: 439-445.
13. Kuhlemeier KV, Lloyd AL, Stover SO. Long-term followup of renal function after spinal cord injury. J Urology 1985; 134: 510-513.
14. Tempkin A, Sullivan G, Paldi J, et al. Radioisotope renography in spinal cord injury. J Urology 1985; 133: 228-230.
15. Price M, Kottke FJ, Olson ME. Renal function in patients with spinal cord injury: The eighth year of a ten-year continuing study. Arch Phys Med Rehabil 1975; 56: 76-79.
16. Kolb KW, Ha CY. Pharmacokinetic and pharmacodynamic alterations in drug therapy caused by spinal cord injury. Phys Med Rehabil 1987; 1: 375-388.
17. Rabkin R, Dahl DC. Hormones and the kidney. In Diseases of the Kidney, RW Schrier & CW Gottschalk, eds, Little, Brown and Co, Boston, 1993, pp 283-303.
18. Nuhlicek CN, Spurr GB, Barboriak JJ, et al. Body composition of patients with spinal cord injury. Eur J Clin Nutr 1988; 42: 765-773.
19. Nakamura H, Ebe N, Ito S, et al. Renal effects of different types of protein in healthy volunteer subjects and diabetic patients. Diabetes Care 1993; 16: 1071-1075.
20. Hostetter TH. Human renal response to a meat meal. Am J Physiol 1986; 250: F613-618.
21. Bosch JP, Saccaggi A, Lauer A, Ronco C, et al. Renal function reserve in humans. Am J Med 1983; 75: 943-950.
22. Nair KS, Pabico RC, Truglia JA, et al. Mechanism of glomerular hyperfiltration after a protein meal in humans. Diabetes Care 1994; 17: 711-715.
23. Wiseman MJ, Hunt R, Goodwin A, et al. Dietary composition and renal function in healthy subjects. Nephron 1987; 46: 37-42.
24. Russell CD, Dubovsky CVD. Measurement of renal function with radionuclides. J Nucl Med 1989; 30: 2053-2057.
25. Russell CD, Thorstad BL, Yester MV, et al. Quantitation of renal function with technetium-99m MAG3. J Nucl Med 1988; 29: 1931-1933.
26. Prenen JAC, de Klerk JMH, van het Schip AD, et al. Technetium-99m-MAG3 versus iodine-123-OIH: Renal clearance and distribution volume as measured by a constant infusion technique. J Nucl Med 1991; 32: 2057-2060.
27. Fine EJ, Axelrod M, Gorkin J, et al. Measurement of effective renal plasma flow: A comparison of methods. J Nucl Med 1987; 28: 1393-1400.
28. Russell CD, Dubovsky CVD. Quantitation of renal function using MAG3. J Nucl Med 1991; 32: 2061-2063.
29. Berriolo A, Touzery C, Riedinger JM, et al. Estimation of Tc-99m-MAG3 plasma clearance from the global renal uptake measured with a gamma camera. Eur J Nucl Med 1991; 32: 619.